Evaluating new diagnostic and prognostic biomarkers in cardiovascular disease

Heart

Volumn 99, Issue 11, 2013, Pages 757-758

  Collinson, Paul O ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CD40 LIGAND; FATTY ACID; MYELOPEROXIDASE; TROPONIN;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CLINICAL EVALUATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; LENGTH OF STAY; LIMIT OF DETECTION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

CORONARY ARTERY DISEASE; EBM;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EVALUATION STUDIES AS TOPIC; HUMANS; PROGNOSIS;

EID: 84877625878     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302887     Document Type: Editorial

References (15)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
2. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
3. Rifai N, Watson ID, Miller WG. Commercial immunoassays in biomarkers studies: researchers beware! Clin Chem 2012;58:1387-8.
4. Rifai N, Annesley TM, Berg JP, et al. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem 2012;58:483-5.
5. Weber M, Rabenau B, Stanisch M, et al. Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes. Thromb Res 2007;120:811-14. (Pubitemid 47418234)
6. Varo N, Nuzzo R, Natal C, et al. Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clin Sci (Lond) 2006;111:341-7. (Pubitemid 44690192)
7. Shih J, Datwyler SA, Hsu SC, et al. Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations. Clin Chem 2008;54:1076-9. (Pubitemid 351793416)
8. Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253-62. (Pubitemid 44093396)
9. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5. (Pubitemid 36379523)
10. Collinson PO, Gaze DC. Ischaemia-modified albumin: clinical utility and pitfalls in measurement. J Clin Pathol 2008;61:1025-8.
11. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
12. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
13. Jaffe AS, Apple FS. High-sensitivity cardiac troponin: hype, help, and reality. Clin Chem 2010;56:342-4.
14. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-8.
15. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128:282-6. (Pubitemid 47262627)